Opko Health reported 83.31M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 6.33M 0.68M
Akebia Therapeutics AKBA:US $ 36.27M 3.15M
ALKERMES ALKS:US $ 155.61M 0.82M
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Amarin AMRN:US $ 225.77M 42.05M
Ardelyx ARDX:US 4.53M 1.04M
Biomarin Pharmaceutical BMRN:US $ 802.32M 15.96M
Bristol Myers Squibb BMY:US $ 2142M 38M
Emergent Biosolutions EBS:US $ 425.5M 24.8M
Esperion Therapeutics ESPR:US $ 29.23M 6.42M
Exact Sciences EXAS:US $ 115.17M 2.21M
Exelixis EXEL:US $ 28.47M 0.97M
Halozyme Therapeutics HALO:US $ 47.76M 6.15M
Laboratory Of America LH:US $ 436.3M 4.4M
Moderna Inc MRNA:US 1.92B 21M
Myriad Genetics MYGN:US $ 15.4M 0.2M
Neurocrine Biosciences NBIX:US $ 29.3M 0.3M
Opko Health OPK:US 83.31M 16.1M
Ptc Therapeutics PTCT:US $ 15M 0.28M
Puma Biotechnology PBYI:US $ 6.66M 0.61M
Quest Diagnostics DGX:US $ 187M 10M
Sarepta Therapeutics SRPT:US $ 208.1M 9.1M
Seattle Genetics SGEN:US $ 319.35M 43.61M
Ultragenyx Pharmaceutical RARE:US $ 21.08M 3.27M
United Therapeutics UTHR:US $ 89.9M 1.7M
Vanda Pharmaceuticals VNDA:US 1.5M 206K